ILCC 2022 Conference Coverage
P

ILCC 2022 Mesothelioma: Updates in Systemic Therapy

By ILCC 2022 Conference Coverage FEATURING Paul Baas
By ILCC 2022 Conference Coverage FEATURING Paul Baas
241 views
August 23, 2022
2 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
04:35
Total Health

Chemo vs. Chemo + Pembro in 1L Pleural Mesothelioma - 2023 ASCO® Dir…

Feat. J. Bauman
15:37
ImmunoTherapy Bridge 2023

What’s New in NSCLC & Mesothelioma Immunotherapy

Feat. A. Morabito
08:14
2023 Texas Lung Cancer Conference Coverage

Updates in Malignant Pleural Mesothelioma

Feat. M. Marmarelis
05:16
Scripps MD Anderson Cancer Center

Recent Updates on Chemo +/- IO in Mesothelioma

Feat. R. Natale
07:11
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Insights: "First Survival Data From the NIPU Trial - …

Feat. A. Helland
22:02
OncoAlert

Significant Advances in Mesothelioma

Feat. G. Mountzios
09:04
Oncology Data Advisor

Discovering Research Advances in Mesothelioma

Feat. S. Kareff, E. Rodriguez
05:39
GRACE

ASCO® 2023 Insights: "Chemo +/- IO for Mesothelioma"

Feat. J. West, C. Lovly, A. Addeo
05:22
ecancer

ESMO 2021 Updates on 1L Nivo+Ipi for Unresectable Malignant Pleural …

Feat. S. Peters
04:33
ecancer

ASCO® 2023 Insights: "Pembro in 1L Treatment for Unresectable A…

Feat. P. Bradbury
08:40
Laura Ridolfi

MESOVAX Clinical Trial of Pembro & Dendritic Cell Vaccine in Adv…

09:56
2020 Virtual ESMO Review

2020 ESMO Updates in Lung Cancer: Does 1L Nivolumab–Ipilimumab Boost…

Feat. M. Dietrich
16:56
WCLC 2022 Conference Coverage

WCLC 2022 on Ipilimumab and Nivolumab in Pretreated Patients With Ma…

Feat. M. Jakopovic
17:52
Memorial Sloan Kettering Cancer Center

Malignant Pleural Mesothelioma: What Do Clinical Trials Suggest on A…

Feat. M. Zauderer
21:36
2021 Virtual ESMO Review

ESMO 2021 Highlights on Stage III NSCLC and Malignant Mesothelioma: …

Feat. T. Owonikoko
21:39
2021 Virtual ESMO Review

ESMO 2021 Q&A Panel Discussion on Lung Cancer

Feat. I. Dagogo-Jack, T. Owonikoko
05:47
GRACE

ASCO Roundtable on 2L Malignant Pleural Mesothelioma: How Encouragin…

Feat. J. West, H. Yu, D. Spigel
07:16
WCLC 2022 Conference Coverage

WCLC 2022 on the Single Arm Phase II Study PEMMELA: Pembrolizumab + …

Feat. L. Huaqing Douma
32:08
Olga Olevsky

Update on Mesothelioma: The Role of VEGF, Position of Immunotherapy,…

05:13
GRACE

Does Immunotherapy Have Activity in Malignant Pleural Mesothelioma?

Feat. M. Das